Drugs in Dev.
Infections and Infectious Diseases
Phase III
Indonesia 
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : COVID-19 Protein Subunit Recombinant Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : University of Indonesia | Diponegoro University | Andalas University | Hasanuddin University
Deal Size : Inapplicable
Deal Type : Inapplicable
Immuno-bridging Study of COVID-19 Protein Subunit Recombinant Vaccine
Details : COVID-19 Protein Subunit Recombinant Vaccine is a Vaccine drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of COVID-19.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
June 27, 2022
Lead Product(s) : COVID-19 Protein Subunit Recombinant Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : University of Indonesia | Diponegoro University | Andalas University | Hasanuddin University
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Inactivated SARS-CoV-2 vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Universitas Padjadjaran | NIHRD, Ministry of Health, Indonesia | Sinovac Biotech
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine
Details : Inactivated SARS-CoV-2 vaccine is a Vaccine drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of COVID-19.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
August 11, 2020
Lead Product(s) : Inactivated SARS-CoV-2 vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Universitas Padjadjaran | NIHRD, Ministry of Health, Indonesia | Sinovac Biotech
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : COVID-19 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Sinovac Biotech
Deal Size : Inapplicable
Deal Type : Inapplicable
Bio Farma Begins Human Trials of Coronavirus Vaccine in Indonesia
Details : In the clinical trial of the 3 Covid-19 vaccines, Bio Farma will work together with the Phase 3 Clinical Trial Research Team, Faculty of Medicine, UNPAD Bandung for the next six months. If the Phase 3 clinical trial goes well, then the next step is to re...
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
August 08, 2020
Lead Product(s) : COVID-19 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Sinovac Biotech
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Rotavirus RV3 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy, Safety and Immunogenicity of Rotavirus RV3 Vaccine (Bio Farma) in Neonates
Details : Bio Farma (Rotavirus RV3 Vaccine) is a Vaccine drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Gastroenteritis.
Product Name : Bio Farma
Product Type : Vaccine
Upfront Cash : Inapplicable
December 04, 2019
Lead Product(s) : Rotavirus RV3 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
